🔎 Trials Near Me

Akèy › Maladi poumon entèstisyèl › Illinois

Etid klinik pou Maladi poumon entèstisyèl nan Illinois

13 etid pou Maladi poumon entèstisyèl ap chèche patisipan nan sit nan Illinois.

Vil nan Illinois

Tèks ofisyèl etid la (Anglè)

Pulmonary Fibrosis Foundation Community Registry

  • Pulmonary Fibrosis Foundation, Chicago
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT05382572

A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

  • Northwestern University, Chicago
  • The University of Chicago Medical Center, Chicago
  • Northshore University Health System, Evanston
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT06806592

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

  • GSK Investigational Site, Chicago
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT05878717

A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

  • Northwestern University, Chicago
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Sep 2, 2026 · NCT07285655

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

  • Clinical Research Site, Chicago
Ap rekriteFaz 2
Laj 18 a 85 · Tout sèks · Mizajou Sep 2, 2026 · NCT07333183

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

  • Northwestern University, Chicago
  • University of Illinois Health, Chicago
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06911632

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • Northwestern University, Chicago
  • Loyola University Medical Center, Maywood
  • Advocate Christ Medical Center, Oak Lawn
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT06388421

Platform Clinical Study for Conquering Scleroderma

  • The University of Chicago Medical Center (UCMC), Chicago
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT06195072

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

  • Northwestern Memorial Hospital, Chicago
  • The University of Chicago Medical Center, Chicago
Ap rekriteFaz 2/3
Laj 18 a 75 · Tout sèks · Mizajou Aug 17, 2026 · NCT06328777

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

  • University of Chicago, Chicago
  • Northwestern University, Evanston
  • Loyola University Health System, Maywood
Ap rekriteEtid obsèvasyon
Laj 21 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT01915511

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

  • Northwestern Memorial Hospital, Clinical Research Unit, Chicago
  • Rush University Medical Center Outpatient Pulmonary Clinic, Chicago
  • UI Health Hospital, Chicago
  • ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT05943535

A Study of the Natural Progression of Interstitial Lung Disease (ILD)

  • University of Chicago, Chicago
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jun 9, 2026 · NCT00470327

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

  • aTyr Investigative Site, Chicago
  • aTyr Investigative Site, Chicago
  • aTyr Investigative Site, Chicago
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou May 7, 2025 · NCT05892614

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.